http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104995207-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70557 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70546 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705 |
| filingDate | 2013-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104995207-B |
| titleOfInvention | The inhibitor of β integrins-G-protein α subunit binding interactions |
| abstract | There is provided herein the compounds for inhibiting the binding interactions between β integrins and G-protein subunit, and the composition comprising the compound such as pharmaceutical composition and related kit.In some embodiments, the compound is antibody or antibody analog, and in other embodiments, the compound is peptide or peptide analogues.The method using the compound is additionally provided, including treats or prevents medical condition, such as method of apoplexy, heart attack, cancer or inflammation. |
| priorityDate | 2012-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1991.